Filing Details
- Accession Number:
- 0000014272-14-000109
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-03-10 16:40:07
- Reporting Period:
- 2014-03-06
- Filing Date:
- 2014-03-10
- Accepted Time:
- 2014-03-10 16:40:07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
14272 | Bristol Myers Squibb Co | BMY | Pharmaceutical Preparations (2834) | 220790350 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1208099 | Lamberto Andreotti | Bristol-Myers Squibb Company 345 Park Avenue New York NY 10154 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.10 Par Value | Acquisiton | 2014-03-06 | 29,240 | $0.00 | 738,383 | No | 4 | M | Direct | |
Common Stock, $0.10 Par Value | Acquisiton | 2014-03-06 | 19,854 | $0.00 | 758,237 | No | 4 | J | Direct | |
Common Stock, $0.10 Par Value | Disposition | 2014-03-06 | 27,454 | $55.56 | 730,783 | No | 4 | F | Direct | |
Common Stock, $0.10 Par Value | Disposition | 2014-03-10 | 100,000 | $55.52 | 630,783 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | J | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock, $0.10 Par Value | Market Share Units | Disposition | 2014-03-06 | 29,240 | $0.00 | 29,240 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
58,480 | 2016-03-06 | No | 4 | M | Direct |
Footnotes
- Represents vesting of one-quarter of market share units granted on March 6, 2012.
- Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor.
- Shares withheld for payment of taxes upon vesting of awards.
- The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $55.22 to $55.89, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%.